Comparison of the Pharmacodynamic Profiles of a Biosimilar Filgrastim and Amgen Filgrastim: Results From a Randomized, Phase I Trial
Annals of Hematology - Germany
doi 10.1007/s00277-010-0973-6
Full Text
Open PDFAbstract
Available in full text
Date
June 22, 2010
Authors
Publisher
Springer Science and Business Media LLC